Full Length Research Paper
References
Ciccolini J, Catalin J, Blachon M, Durand A (2001). Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid–liquid extraction. J. Chromatogr. B: Biomed. Sci. Appl. 759(2): 299-306. Crossref |
||||
Esrafili A, Yamini Y, Shariati S (2007). Hollow fiber-based liquid phase microextraction combined with high-performance liquid chroma-tography for extraction and determination of some antidepressant drugs in biological fluids. Anal. Chim. Acta. 604(2):127-133. Crossref |
||||
Gan S, Ismail R, Wan Adnan W, Wan Z (2002). Method development and validation of a high-performance liquid chromatographic method for tramadol in human plasma using liquid–liquid extraction. J. Chromatogr. B. 772(1):123-129. Crossref |
||||
ICH (2005). Validation of Analytical Procedures: Text and Methodology. International conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. International Conference on Harmonisation, Geneva, Switzerland. View | ||||
Lee J, Seo JH, Kim DH (2002). Determination of tizanidine in human plasma by gas chromatography–mass spectrometry. Analyst 127(7):917-920. Crossref |
||||
Lister AS (2005). Validation of HPLC methods in Pharmaceutical Analysis, 1 ed. Elseveir Inc., UK. | ||||
Meythaler JM, Guin-Renfroe S, Johnson A, Brunner RM (2001). Prospective assessment of tizanidine for spasticity due to acquired brain injury. Arch. Phys. Med. Rehab. 82(9):1155-1163. Crossref |
||||
Momo K, Homma M, Osaka Y, Inomata S, Tanaka M, Kohda Y (2010). Effects of mexiletine, a CYP1A2 inhibitor, on tizanidine pharmacokinetics and pharmacodynamics. J. Clin. Pharmacol. 50(3):331-337. Crossref |
||||
Nirogi RV, Kandikere VN, Shukla M, Mudigonda K, Maurya S (2006). Quantification of tizanidine in human plasma by liquid chromatography coupled to tandem mass spectrometry. Rapid Commun. Mass Spectr. 20(15):2286-2292. Crossref |
||||
Qi ML, Wang P, Wang L (2003). Validated liquid chromatography method for assay of tizanidine in drug substance and formulated products. Analyt. Chim. Acta. 478(2):171-177. Crossref |
||||
Saper JR, Lake AE, Cantrell DT, Winner PK, White JR (2002). Chronic Daily Headache Prophylaxis With Tizanidine: A Doubleâ€Blind, Placeboâ€Controlled, Multicenter Outcome Study. Headache 42(6):470-482. Crossref |
||||
Shanker G, Kumar CK, Gonugunta CSR, Kumar BV, Veerareddy PR (2009). Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets. AAPS Pharmscitech. 10(2): 530-539. Crossref |
||||
Siddiqui FA, Arayne MS, Sultana, N, Qureshi F (2011). Development and validation of stability-indicating HPLC method for the simultaneous determination of paracetamol, tizanidine, and diclofenac in pharmaceuticals and human serum. J. AOAC Int. 94(1): 150-158. Pubmed | ||||
Sweetman SC (2009). Martindale: The complete Drug Reference, 36th ed. Pharmaceutical Press, London. | ||||
Ulu ST (2012). Sensitive spectrofluorimetric determination of tizanidine in pharmaceutical preparations, human plasma and urine through derivatization with dansyl chloride. Luminescence 27(5):426-430. Crossref |
||||
Wagstaff A, Bryson H (1997). Tizanidine: A review of its pharmacology clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs 53(3): 435-452. Crossref |
||||
Xiong C, Ruan J, Cai Y, Tang Y (2009). Extraction and determination of some psychotropic drugs in urine samples using dispersive liquid–liquid microextraction followed by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 49(2): 572-578. Crossref |
||||
Zheng R, Wu YH, Jiang DX, Zhang D (2012). Determination of metabolite of nicergoline in human plasma by high-performance liquid chromatography and its application in pharmacokinetic studies. J. Pharm. Anal. 2(1):62-66. Crossref |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0